The Feasibility and Accuracy of Exhaled CO2 to Measure Cardiac Output in Ventilated Patients Without Tracheal Intubation

NCT ID: NCT00783679

Last Updated: 2012-04-25

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-11-30
• Study Completion Date: 2010-12-31

Brief Summary

The purpose of this study is to test the accuracy of a new noninvasive way to measure how much blood our heart pumps per minute. This new way measures the heart's pumping activity from outside the body, instead of breaking the skin and measuring it from the inside.

Subjects will breathe normally through a mask while we record how fast and how much air they are breathing. We will have them "re-breathe" some of the air they breathed out by adjusting the ventilator. During this time, we will use the air breathed out to calculate how much blood per minute the subject's heart is pumping. We will also measure how much blood the heart is pumping at this time by injecting fluid into the catheter in the neck and then drawing about 1 teaspoon of blood from the catheters in the neck and arm. We will compare the calculated and measured values of the amount of blood pumped out of the heart for accuracy.

After we complete this procedure, we will remove the mask and allow you to rest for 10-30min. Following the rest period, we will repeat the process and collect a second set of measurements. We will draw a total of 4 teaspoons of blood for the study.

If you cannot comfortably breathe along with the ventilator, we will withdraw you from the study. If you want to stop taking part in the study at any time, let the study doctor know that you wish to withdraw. We will take off the mask, and your time in the study will end. This decision will not affect your regular medical care.

Conditions

Cardiac Physiology; Cardiac Output

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Blinding Strategy: NONE

Study Groups

1

Twenty adult spontaneously breathing patients without intubation and mechanical ventilation recruited from the cardiac catheterization laboratory. All will be post-heart-transplant patients coming for yearly evaluation.

Group Type: OTHER

NICO device

Intervention Type: DEVICE

Measurement of cardiac output and simultaneous blood sampling.

The subjects' cardiac output will be measured by NICO device and also by thermodilution method. Simultaneously blood samples will be drawn from the pulmonary artery catheter and arterial line. The calculated and measured cardiac output values will be compared for accuracy.

Interventions

NICO device

Measurement of cardiac output and simultaneous blood sampling.

The subjects' cardiac output will be measured by NICO device and also by thermodilution method. Simultaneously blood samples will be drawn from the pulmonary artery catheter and arterial line. The calculated and measured cardiac output values will be compared for accuracy.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Patient is already monitored with a pulmonary artery catheter and arterial line (not for the purpose of this study);

2. Hemodynamic stability.

Exclusion Criteria

1. Patients with facial deformity, heavy beard or moustache which prevents good seal between the mask and the face;

2. Patients who have central nervous system disorders that might be adversely affected by CO2 rebreathing, such as head trauma patients with increased intracranial pressure;

3. Patients with severe tricuspid regurgitation;

4. Patients with intra-cardiac shunts;

5. Patients who cannot cooperate and synchronize with the ventilator;

6. Patients with unstable respiratory conditions, such as acute respiratory failure;

7. Patients who have claustrophobia and cannot wear the mask.

8. Patients with aortic stenosis.

9. Patients with left main coronary artery disease.

10. Pregnancy.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Massachusetts General Hospital

OTHER

Sponsor Role: lead

Responsible Party

Robert M. Kacmarek

Professor of Anesthesia, Director of Respiratory Care Services

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Robert Kacmarek, PhD, RRT

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Massachusetts General Hospital

Boston, Massachusetts, United States

Countries

United States

Other Identifiers

2007-P-000222

Identifier Type: -

Identifier Source: org_study_id